WO2008096820A1 - ビフェニル誘導体 - Google Patents

ビフェニル誘導体 Download PDF

Info

Publication number
WO2008096820A1
WO2008096820A1 PCT/JP2008/052044 JP2008052044W WO2008096820A1 WO 2008096820 A1 WO2008096820 A1 WO 2008096820A1 JP 2008052044 W JP2008052044 W JP 2008052044W WO 2008096820 A1 WO2008096820 A1 WO 2008096820A1
Authority
WO
WIPO (PCT)
Prior art keywords
hydrogen atom
biphenyl derivative
represent
alkyl group
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/052044
Other languages
English (en)
French (fr)
Inventor
Arata Yanagisawa
Wakako Otsubo
Kimihisa Ueno
Michihiko Suzuki
Masahiro Matsubara
Satoshi Saeki
Kozo Yao
Akinori Hamaguchi
Seiji Aratake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd, Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of WO2008096820A1 publication Critical patent/WO2008096820A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

　一般式（Ｉ） ［式中、Ｒ１は、－ＣＯＯＲ３（式中、Ｒ３は水素原子等を表す）等を表し、Ｒ２ａおよびＲ２ｂは、同一または異なって、水素原子等を表し、 Ｗは、 ［式中、Ｒ６は、置換基を有していてもよい低級アルキル等を表し、Ｒ７ａおよびＲ７ｂは、同一または異なって、水素原子等を表し、Ｒ８は、置換基を有していてもよい低級アルキル等を表す］等を表す］で表されるビフェニル誘導体またはその薬学的に許容される塩を提供する。
PCT/JP2008/052044 2007-02-07 2008-02-07 ビフェニル誘導体 Ceased WO2008096820A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-027535 2007-02-07
JP2007027535 2007-02-07

Publications (1)

Publication Number Publication Date
WO2008096820A1 true WO2008096820A1 (ja) 2008-08-14

Family

ID=39681724

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/052044 Ceased WO2008096820A1 (ja) 2007-02-07 2008-02-07 ビフェニル誘導体

Country Status (1)

Country Link
WO (1) WO2008096820A1 (ja)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119700A1 (ja) 2009-04-17 2010-10-21 興和株式会社 新規な３-ヘテロアリールピリミジン-４-(３ｈ)-オン構造を有する化合物及びこれを含有する医薬
WO2010137336A1 (ja) 2009-05-29 2010-12-02 興和株式会社 新規なα－フェノキシベンゼン酢酸誘導体及びこれを含有する医薬
WO2011024468A1 (ja) 2009-08-27 2011-03-03 興和株式会社 新規なスルホンアミド誘導体及びこれを含有する医薬
WO2011040004A1 (ja) 2009-09-29 2011-04-07 興和株式会社 新規なフェニルピリジン誘導体及びこれを含有する医薬
WO2011105099A1 (ja) * 2010-02-25 2011-09-01 興和株式会社 新規な４－アルコキシピリミジン構造を有する化合物及びこれを含有する医薬
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2011161030A1 (de) 2010-06-21 2011-12-29 Sanofi Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren
WO2012004269A1 (de) 2010-07-05 2012-01-12 Sanofi ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012004270A1 (de) 2010-07-05 2012-01-12 Sanofi Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012010413A1 (de) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012124311A1 (ja) 2011-03-14 2012-09-20 興和株式会社 新規なフェニルピリジン誘導体及びこれを含有する医薬
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility
CN110669012A (zh) * 2019-11-28 2020-01-10 陈志龙 一类氟取代的苯并咪唑衍生物及其制备方法与医药领域的应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597813A (ja) * 1991-03-19 1993-04-20 Merck & Co Inc アンギオテンシンｉｉ拮抗剤としての酸性官能基を有するイミダゾール誘導体
JPH05112533A (ja) * 1991-05-08 1993-05-07 Upjohn Co:The イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
JP2006515566A (ja) * 2002-08-10 2006-06-01 ベセスダ ファーマシューティカルズ， インコーポレイテッド 体液貯溜、浮腫またはうっ血性心不全を誘発しない新規ｐｐａｒリガンド

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0597813A (ja) * 1991-03-19 1993-04-20 Merck & Co Inc アンギオテンシンｉｉ拮抗剤としての酸性官能基を有するイミダゾール誘導体
JPH05112533A (ja) * 1991-05-08 1993-05-07 Upjohn Co:The イミダゾベンゾキノン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤
JP2006515566A (ja) * 2002-08-10 2006-06-01 ベセスダ ファーマシューティカルズ， インコーポレイテッド 体液貯溜、浮腫またはうっ血性心不全を誘発しない新規ｐｐａｒリガンド

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010119700A1 (ja) * 2009-04-17 2012-10-22 興和株式会社 新規な３−ヘテロアリールピリミジン−４−（３ｈ）−オン構造を有する化合物及びこれを含有する医薬
EP2420501A4 (en) * 2009-04-17 2012-08-29 Kowa Co NOVEL COMPOUND HAVING 3-HETEROARYLPYRIMIDIN-4- (3H) -ONE STRUCTURE AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
US8664226B2 (en) 2009-04-17 2014-03-04 Kowa Company, Ltd. Compound having 3-heteroarylpyrimidin-4-(3H)-one structure and pharmaceutical preparation containing same
WO2010119700A1 (ja) 2009-04-17 2010-10-21 興和株式会社 新規な３-ヘテロアリールピリミジン-４-(３ｈ)-オン構造を有する化合物及びこれを含有する医薬
WO2010137336A1 (ja) 2009-05-29 2010-12-02 興和株式会社 新規なα－フェノキシベンゼン酢酸誘導体及びこれを含有する医薬
WO2011024468A1 (ja) 2009-08-27 2011-03-03 興和株式会社 新規なスルホンアミド誘導体及びこれを含有する医薬
US8778954B2 (en) 2009-09-29 2014-07-15 Kowa Company, Ltd. Phenylpyridine derivative and medicinal agent comprising same
WO2011040004A1 (ja) 2009-09-29 2011-04-07 興和株式会社 新規なフェニルピリジン誘導体及びこれを含有する医薬
WO2011105099A1 (ja) * 2010-02-25 2011-09-01 興和株式会社 新規な４－アルコキシピリミジン構造を有する化合物及びこれを含有する医薬
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2011161030A1 (de) 2010-06-21 2011-12-29 Sanofi Heterocyclisch substituierte methoxyphenylderivate mit oxogruppe, verfahren zu ihrer herstellung und ihre verwendung als gpr40 rezeptor modulatoren
WO2012004270A1 (de) 2010-07-05 2012-01-12 Sanofi Spirocyclisch substituierte 1,3-propandioxidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012010413A1 (de) 2010-07-05 2012-01-26 Sanofi Aryloxy-alkylen-substituierte hydroxy-phenyl-hexinsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012004269A1 (de) 2010-07-05 2012-01-12 Sanofi ( 2 -aryloxy -acetylamino) - phenyl - propionsäurederivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
WO2012124311A1 (ja) 2011-03-14 2012-09-20 興和株式会社 新規なフェニルピリジン誘導体及びこれを含有する医薬
US9315493B2 (en) 2011-03-14 2016-04-19 Kowa Company, Ltd. Phenylpyridine derivative and drug containing same
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013068486A1 (en) 2011-11-08 2013-05-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of male infertility
CN110669012A (zh) * 2019-11-28 2020-01-10 陈志龙 一类氟取代的苯并咪唑衍生物及其制备方法与医药领域的应用

Similar Documents

Publication Publication Date Title
WO2008123469A1 (ja) ６員環アミド化合物およびその用途
WO2009063990A1 (ja) ベンズアゼピノン化合物
PH12012501711A1 (en) [5,6] heterocyclic compound
MX2010008745A (es) Inhibidor de fibrosis.
PH12012501689A1 (en) 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv intergrase inhibitor
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
WO2007092642A3 (en) Polymer formulations of cetp inhibitors
UA94065C2 (en) Dihydropseudoerythromycin derivatives
MEP6908A (xx) Piridin -4-ilmetilamida za borbu protiv štetočina
WO2008153159A1 (ja) アミン化合物及びその医薬用途
MY148469A (en) Spiro-ring compound and use thereof for medical purposes
MX2010003394A (es) Derivado de gamma-aminoacido biciclico.
EP1864665A4 (en) IMMUNOSUPPRESSIVE AGENT AND ANTI-TUMOR AGENT COMPRISING A HETEROCYCLIC COMPOUND AS ACTIVE INGREDIENT
EP1889842A4 (en) HETEROCYCLIC CONNECTION
WO2008001921A3 (en) Dermatological anti-wrinkle agent
WO2005021544A3 (en) N3-substituted imidazopyridine-derivatives as c-kit inhibitors
WO2011113798A3 (en) Inhibitors of semicarabazide - sensitive amine oxidase
WO2010066629A3 (en) Novel azaindoles
WO2008149834A1 (ja) ピリミドジアゼピノン誘導体
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
TNSN08369A1 (en) Benzimidazole derivatives
WO2006067392A3 (en) Indole derivatives for the treatment of tuberculosis
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2007074915A8 (en) Water-soluble benzoazepine compound and its pharmaceutical composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08710923

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08710923

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP